CYZONE - 13537-435-01 - (Octinoxate, Octocrylene, Oxybenzone, Octisalate, Titanium Dioxide, and Ensulizole)

Alphabetical Index


Drug Information of CYZONE

Product NDC: 13537-435
Proprietary Name: CYZONE
Non Proprietary Name: Octinoxate, Octocrylene, Oxybenzone, Octisalate, Titanium Dioxide, and Ensulizole
Active Ingredient(s): .03; .075; .05; .07; .06; .468    g/g; g/g; g/g; g/g; g/g; g/g & nbsp;   Octinoxate, Octocrylene, Oxybenzone, Octisalate, Titanium Dioxide, and Ensulizole
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of CYZONE

Product NDC: 13537-435
Labeler Name: Ventura Corporation LTD.
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20120914

Package Information of CYZONE

Package NDC: 13537-435-01
Package Description: 60 g in 1 TUBE (13537-435-01)

NDC Information of CYZONE

NDC Code 13537-435-01
Proprietary Name CYZONE
Package Description 60 g in 1 TUBE (13537-435-01)
Product NDC 13537-435
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Octinoxate, Octocrylene, Oxybenzone, Octisalate, Titanium Dioxide, and Ensulizole
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20120914
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Ventura Corporation LTD.
Substance Name ENSULIZOLE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE
Strength Number .03; .075; .05; .07; .06; .468
Strength Unit g/g; g/g; g/g; g/g; g/g; g/g
Pharmaceutical Classes

Complete Information of CYZONE


General Information